✦ LIBER ✦

Activity of CYP2E1 measured by the chlorzoxazone test in patients with non-alcoholic steatohepatitis and activation of stellate cells

✍ Scribed by David Semela; Monika Ledermann; Arthur Zimmermann; Jean-Francois Dufour

Book ID: 118565442
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 108 KB
Volume: 36
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(02)80526-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic Repeat Polymorphism in the Regul

Genetic Repeat Polymorphism in the Regulating Region of CYP2E1: Frequency and Relationship With Enzymatic Activity in Alcoholics

✍ E. Plee-Gautier; F. Foresto; R. Ferrara; P. Bodénez; B. Simon; M. Manno; F. Bert 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Assessment of ifosfamide pharmacokinetic

Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma

✍ Rashmi Chugh; Thomas Wagner; Kent A. Griffith; Jeremy M.G. Taylor; Dafydd G. Tho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

## Abstract ## BACKGROUND. Ifosfamide is a chemotherapeutic agent that requires cytochrome P450 3A (CYP3A) for bioactivation and metabolism. To the authors' knowledge, the correlation between dose, pharmacokinetics, CYP3A, and toxicity has not been fully evaluated. A randomized Phase II trial was

Increased lipid peroxidation in patients

Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane

✍ Masayoshi Konishi; Motoh Iwasa; Jun Araki; Yoshinao Kobayashi; Akira Katsuki; Ya 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Phase 2 study of mapatumumab, a fully hu

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer

✍ Greco, F. Anthony; Bonomi, Philip; Crawford, Jeffrey; Kelly, Karen; Oh, Yun; Hal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Safety and activity of alectinib against

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study

✍ Gadgeel, Shirish M; Gandhi, Leena; Riely, Gregory J; Chiappori, Alberto A; West, 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 385 KB